Previously we have demonstrated that light can be used to control the release of insulin in diabetic animals, followed by a reduction in blood glucose. This is accomplished using a photoactivated depot (PAD) of insulin injected into the skin, and irradiated by a small external LED light source. In this work for the first time we demonstrate dose-response, showing that we can vary insulin release and commensurate blood glucose reduction by varying the amount of light administered. In addition to demonstrating dose-response, we have shown multi-day depot response, with insulin being released on two different days from the same depot. The material used in these studies was CD-insulin, a form of insulin that has a highly non-polar cyclododecyl group attached, markedly reducing the solubility of the modified material, and allowing it to form a depot upon injection. Upon photolysis, the cyclododecyl group is removed, releasing fully native, soluble insulin. Variable response and multi-day response as demonstrated strongly support the potential utility of the PAD approach for the variable and extended release of therapeutic peptides.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529906 | PMC |
http://dx.doi.org/10.1016/j.bmcl.2023.129388 | DOI Listing |
Brain Res Bull
December 2024
Key Laboratory of Biorheological Science and Technology of Ministry of Education, Chongqing University, Chongqing, China; Chongqing Key Laboratory of Artificial Intelligence and Service Robot Control Technology, Chongqing, China. Electronic address:
The effectiveness of rehabilitation is contingent upon the motor recovery process which typically involves long-term motor skill re-acquisition. Given that the learning process can be modulated by task difficulty, elucidating the underlying neural mechanism is essential for optimizing rehabilitation prescription to suit different patient conditions. This study aimed to investigate the impact of task difficulty on cortical response during force-control training via electroencephalography (EEG).
View Article and Find Full Text PDFInt J Clin Oncol
January 2025
Division of Medical Oncology, Hematology and Infectious Disease, Fukuoka University Hospital, 7-45‑1, Nanakuma, Jonan‑Ku, Fukuoka, 814‑0180, Japan.
Support Care Cancer
October 2024
Genolier Cancer Center, Genolier, Switzerland.
Introduction: Over the past decade, several randomized controlled trials have compared single-day dexamethasone (dexamethasone-sparing) regimens to the current standard multi-day dexamethasone antiemetic regimen for chemotherapy-induced nausea and vomiting (CINV). The aim of this systematic review and meta-analysis is to compare the efficacy and safety of dexamethasone-sparing regimens to standard multi-day dexamethasone, used for the prophylaxis of CINV.
Methods: Ovid Medline and Embase were searched from database inception to March 2024.
Intensive Care Med Exp
October 2024
Adult Intensive Care, Erasmus Medical Center, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
Background: Popularity of electrical impedance tomography (EIT) and esophageal pressure (Pes) monitoring in the ICU is increasing, but there is uncertainty regarding their bedside use within a personalized ventilation strategy. We aimed to gather insights about the current experiences and perceived role of these physiological monitoring techniques, and to identify barriers and facilitators/solutions for EIT and Pes implementation.
Methods: Qualitative study involving (1) a survey targeted at ICU clinicians with interest in advanced respiratory monitoring and (2) an expert focus group discussion.
Comput Biol Med
November 2024
Physiological Controls Research Center, University Research and Innovation Center, Obuda University, Bécsi út 96/b, Budapest, 1034, Hungary; Biomatics and Applied Artificial Intelligence Institute, John von Neumann Faculty of Informatics, Obuda University, Bécsi út 96/b, Budapest, 1034, Hungary. Electronic address:
For individuals diagnosed with diabetes mellitus, it is crucial to keep a record of the carbohydrates consumed during meals, as this should be done at least three times daily, amounting to an average of six meals. Unfortunately, many individuals tend to overlook this essential task. For those who use an artificial pancreas, carbohydrate intake proves to be a critical factor, as it can activate the insulin pump in the artificial pancreas to deliver insulin to the body.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!